JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$870M |
| 2 |
Meta Platforms (Facebook)
META
|
+$692M |
| 3 |
Johnson & Johnson
JNJ
|
+$495M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$408M |
| 5 |
Microsoft
MSFT
|
+$390M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$790M |
| 2 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$736M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$699M |
| 4 |
SLB Ltd
SLB
|
+$401M |
| 5 |
NWS
THE NEWS CORPORATION LTD CL-B
NWS
|
+$346M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 17.89% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 10.35% |
| 4 | Technology | 10.34% |
| 5 | Energy | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
State Street
STT
$48.2B
| $617M | 0.18% |
9,376,609
-745,025
| -7% | -$51M |
2013 Q2
1 quarter
|
|
127
3M
MMM
$83.1B
| $613M | 0.18% |
6,142,790
-171,329
| -3% | -$16.7M |
2013 Q2
1 quarter
|
|
128
W.W. Grainger
GWW
$60.9B
| $604M | 0.18% |
2,307,031
+329,030
| +17% | +$85.6M |
2013 Q2
1 quarter
|
|
|
ALXN
129
DELISTED
Alexion Pharmaceuticals
ALXN
| $591M | 0.18% |
5,089,092
+1,319,619
| +35% | +$145M |
2013 Q2
1 quarter
|
|
130
PNC Financial Services
PNC
$87.5B
| $588M | 0.17% |
8,114,937
+1,829,770
| +29% | +$137M |
2013 Q2
1 quarter
|
|
131
LyondellBasell Industries
LYB
$19.5B
| $585M | 0.17% |
7,989,069
+405,546
| +5% | +$28.2M |
2013 Q2
1 quarter
|
|
132
Delta Air Lines
DAL
$53.6B
| $584M | 0.17% |
24,752,626
+9,818,868
| +66% | +$205M |
2013 Q2
1 quarter
|
|
133
Amphenol
APH
$214B
| $583M | 0.17% |
120,548,512
+27,104,464
| +29% | +$132M |
2013 Q2
1 quarter
|
|
|
BRCM
134
DELISTED
BROADCOM CORP CL-A
BRCM
| $582M | 0.17% |
22,380,237
+32,096
| +0.1% | +$906K |
2013 Q2
1 quarter
|
|
135
Vertex Pharmaceuticals
VRTX
$130B
| $578M | 0.17% |
7,626,134
+748,645
| +11% | +$59.6M |
2013 Q2
1 quarter
|
|
|
CTRA
136
DELISTED
Coterra Energy
CTRA
| $569M | 0.17% |
15,238,282
+3,624,458
| +31% | +$136M |
2013 Q2
1 quarter
|
|
137
Healthpeak Properties
DOC
$13B
| $567M | 0.17% |
15,196,283
-147,495
| -1% | -$5.75M |
2013 Q2
1 quarter
|
|
138
PUT
Gilead Sciences
GILD
$187B
| $567M | 0.17% |
9,011,400
-126,100
| -1% | -$7.54M |
2013 Q2
1 quarter
|
|
139
Infosys
INFY
$43.5B
| $557M | 0.17% |
92,655,688
+4,458,336
| +5% | +$26.4M |
2013 Q2
1 quarter
|
|
140
Walmart Inc
WMT
$884B
| $553M | 0.16% |
22,424,232
+2,839,680
| +14% | +$71.6M |
2013 Q2
1 quarter
|
|
|
KMP
141
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
| $551M | 0.16% |
6,906,790
-136,063
| -2% | -$11.3M |
2013 Q2
1 quarter
|
|
142
Marathon Petroleum
MPC
$128B
| $551M | 0.16% |
17,120,022
+3,885,316
| +29% | +$137M |
2013 Q2
1 quarter
|
|
143
Costco
COST
$420B
| $547M | 0.16% |
4,751,787
+210,463
| +5% | +$24.3M |
2013 Q2
1 quarter
|
|
144
Kimberly-Clark
KMB
$32.5B
| $542M | 0.16% |
5,998,694
+584,429
| +11% | +$54.1M |
2013 Q2
1 quarter
|
|
145
Illinois Tool Works
ITW
$75.4B
| $539M | 0.16% |
7,070,009
+527,710
| +8% | +$38.6M |
2013 Q2
1 quarter
|
|
146
Archer Daniels Midland
ADM
$38.9B
| $534M | 0.16% |
14,497,809
+104,133
| +0.7% | +$3.79M |
2013 Q2
1 quarter
|
|
147
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.3B
| $531M | 0.16% |
5,796,513
+742,272
| +15% | +$68.1M |
2013 Q2
1 quarter
|
|
148
Carlisle Companies
CSL
$12.8B
| $526M | 0.16% |
7,482,849
+198,032
| +3% | +$13.4M |
2013 Q2
1 quarter
|
|
149
Prudential Financial
PRU
$38.9B
| $521M | 0.15% |
6,686,456
-254,141
| -4% | -$19.9M |
2013 Q2
1 quarter
|
|
150
Phillips 66
PSX
$112B
| $520M | 0.15% |
9,000,399
-1,119,289
| -11% | -$64.9M |
2013 Q2
1 quarter
|
|
Similar funds
JP Morgan Chase's Q3 2013 Portfolio in Review
As of Q3 2013, JP Morgan Chase held 4,631 positions worth $337B, up 7.6% from $314B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
JP Morgan Chase's Q3 2013 filing shows 262 new, 1,958 increased, 1,721 reduced and 269 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class B: 9,682,912 shares worth $323M. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $790M.
By sector, the portfolio is most concentrated in Miscellaneous at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class B: 9,682,912 shares worth $323M.
- JP Morgan Chase added most to iShares MSCI EAFE ETF in Q3 2013, an estimated $870M increase.
- JP Morgan Chase's biggest Q3 2013 reduction was COVIDIEN PLC COM SHS NEW (IRELAND), cutting an estimated $790M.
- JP Morgan Chase fully exited THE NEWS CORPORATION LTD CL-B in Q3 2013, selling an estimated $346M.
- JP Morgan Chase's ten largest holdings make up 15% of its $337B portfolio in Q3 2013.
- JP Morgan Chase opened 262 new positions and closed 269 in Q3 2013.
- JP Morgan Chase's portfolio value rose 7.6% quarter-over-quarter to $337B.
Based on JP Morgan Chase's 13F filing for Q3 2013, filed 31 Oct 2013.